PDCD1 and neoplasm: In our study, the effects of PD-1 blockade on the tumor biology/genetics and the immune system in the same patient were explored based on the hypothesis that a combination of immunological and genetic biomarkers can improve the specificity of predicting clinical response to PD-1 blockade compared with either alone.